宏源药业 (301246.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(宏源药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 16.008.0015.0010.0019.00-22.0032.00
 单季度销售净利率(%) 7.00-2.006.00-13.00-28.0039.00
 单季度净资产收益率ROE(%) 1.00-1.00-2.00-7.0010.00
 单季度总资产净利率ROA(%) 1.00-1.00-1.00-4.007.00
单季度财务摘要:
 单季度营业总收入(元) 426,063,885.00496,167,048.00561,081,337.00493,723,786.00503,909,820.00-450,158,621.00451,160,829.00
 单季度营业总成本(元) 393,251,587.00510,203,945.00526,165,069.00493,078,534.00435,832,955.00-391,257,451.00343,284,359.00
 单季度营业收入(元) 426,063,885.00496,167,048.00561,081,337.00493,723,786.00503,909,820.00-450,158,621.00451,160,829.00
 单季度营业利润(元) 35,165,806.00-16,452,367.0044,500,203.001,721,101.0075,875,568.00-143,264,158.00192,556,842.00
 单季度利润总额(元) 35,078,652.00-16,426,189.0038,891,339.00328,462.0075,764,452.00-141,194,599.00192,303,400.00
 单季度净利润(元) 31,199,062.00-9,131,553.0031,276,739.00279,074.0064,744,366.00-125,739,418.00176,797,540.00
 单季度归属母公司股东的净利润(元) 31,199,062.00-9,131,553.0031,276,739.00279,074.0064,744,366.00-125,739,418.00176,797,540.00
 单季度经营活动产生的现金流量(元) -89,497,668.00-74,266,014.00219,800,326.00-124,648,072.0014,364,159.0079,161,267.0010,455,963.00101,950,408.00
 单季度投资活动产生的现金流量(元) 257,209,141.00-366,321,050.00458,371,606.00-2,033,662,880.00-127,613,912.00--28,713,899.00-122,809,002.00
 单季度筹资活动产生的现金流量(元) -3,433,916.00-25,691,839.00-49,012,661.0021,736,770.002,206,058,206.00-47,046,934.00223,274,337.00
 单季度现金及现金等价物净增加(元) 165,567,618.00-466,452,908.00629,578,835.00-2,134,949,369.002,091,508,428.00-31,032,294.00202,116,662.00

前瞻产业研究院